Over the past decade, the world has witnessed an unprecedented increase in the use of antiretroviral therapy, which has saved the lives of tens of millions of people living with HIV/AIDS.

Increased use of HIV medicines has been accompanied by the emergence of HIV drug resistance, the levels of which have steadily increased in recent years. As a result, many people find that their HIV medicines aren’t working due to resistance. The WHO Global Action Plan provides a framework for action for all stakeholders to monitor, prevent, and respond to HIV drug resistance. This includes five areas for joint action by global partners:
Improving prevention and response
Ensuring monitoring and surveillance
Supporting research and innovation;
Strengthening laboratory capacity; and
Reinforcing governance and enabling mechanisms.

More information: https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/hiv/treatment/hiv-drug-resistance/